You might not believe what you're about to see is real, but I assure you the video has been left unedited. It's so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity.
|
|
| A message from our valued partners and today's trending news. | | | |
|
| Tesla Execs Are Freaking Out - Ad
You might not believe what you're about to see is real, but I assure you the video has been left unedited. It's so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. More Info ➔ | | | | | | Exposed: 3 Cent Crypto to Explode December 16th? - Ad
Chris Rowe, the man who spotted 44 different coins that have returned over 100%, is now making the biggest crypto call of his ENTIRE career.... Because a powerful crypto event will trigger on December 16th... Sending hundreds of tiny cryptos soaring 5X, 50X, even 100X -- in just days. See the details | | | | | | Weekend Round-Up: Elon Musk's Spacex, Tesla's New Model, And More
This weekend saw major developments in tech and automotive industries, including SpaceX's Starship enhancements, Tesla's plans for the affordable Model Q, GM's shift in Cruise robotaxi strategy, Lucid's Gravity SUV achieving a 450-mile range, and BMW's unexpected retraction of praise for Tesla's Full Self-Driving system. More Info ➔ | | | | | | 5 Real Estate Stocks That Should be on Your Radar Now - Ad
Lucrative investment opportunities are always found in real estate. Real estate stocks can be an alternative way to invest in this area, without needing to purchase property. Here are the hottest stocks in this field.
| | | | By clicking the link above you will automatically opt-in to receive emails from SmartMoneyTrading and agree to Privacy Policy | | | | | | CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
The majority of caregivers of patients with tuberous sclerosis complex (TSC) planned to continue Epidiolex treatment, citing benefits like reduced seizure frequency and improvements in cognition and communication. That's according to data from the BECOME-TSC (BEhavior, COgnition, and More with Epidiolex) caregiver survey, revealed by Jazz Pharmaceuticals plc (NASDAQ: JAZZ). New data on Epidiolex is being presented at the American Epilepsy Society (AES) 2024 Annual Meeting, being held December 6-10 in Los Angeles, California via nine company-sponsored posters.Epidiolex is the only FDA-appro More Info ➔ | | | | | |
| Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040 © 2024 Musth | TrendAdvisor | All rights reserved.
Unsubscribe | | | | |
No comments:
Post a Comment